Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ConmedMEX:CNMD 80 Operating Margin % is 10.60% as of Jun. 2026, which is 35% above its 10-year median of 7.87. GuruFocus rates MEX:CNMD with a GF Score™ of 80/100 and a GF Value™ of MXN945.33. The stock has 5 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Conmed ranks better than 60.2% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Conmed's Operating Income for the
three
months ended in Jun. 2026 was MXN635 Mil. Conmed's Revenue for the
three
months ended in Jun. 2026 was MXN5,994 Mil. Therefore, Conmed's Operating Margin % for the quarter that ended in Jun. 2026 was 10.60%.
Good Sign:
Conmed Corp operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Conmed's Operating Margin % or its related term are showing as below:
MEX:CNMD'
s Operating Margin % Range Over the Past 10 Years
Min: 4.93 Med: 7.87 Max: 15.33
Current: 8.04
MEX:CNMD's Operating Margin % is ranked better than 60.2% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: 3.24
vs MEX:CNMD: 8.04
Conmed's 5-Year Average Operating Margin % Growth Rate was 9.20% per year.
Conmed's Operating Income for the
three
months ended in Jun. 2026 was MXN635 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was MXN1,971 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Conmed Operating Margin % Related Terms
Conmed Operating Margin % Historical Data
* Premium members only.
The historical data trend for Conmed's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CNMD vs ATEC, AORT, IRMD: Operating Margin % Comparison
For the Medical Devices subindustry, Conmed's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Conmed Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Conmed's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Conmed's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Conmed (MEX:CNMD) has a Operating Margin % of 10.60% as of Jun. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Conmed and its competitors. This is 35% above median its historical median of 7.87. Over the past decade, Conmed's Operating Margin % has ranged from 4.93 to 15.33. According to the industry distribution chart, Conmed ranks #324 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 39.8%.
Is Conmed's Operating Margin % too high?
Conmed's current Operating Margin % of 10.60% is 35% above median its 10-year median of 7.87. Over the past 10 years, this metric has ranged from a low of 4.93 to a high of 15.33. The Medical Devices & Instruments industry median Operating Margin % is 3.24. Conmed's value of 10.60% is 227.2% above this industry median. Based on the distribution chart, Conmed ranks #324 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Conmed has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Conmed's Operating Margin % compare to ATEC and AORT?
According to the Medical Devices & Instruments industry distribution chart, Conmed ranks #324 out of 814 companies for Operating Margin %. This puts Conmed in the upper half of its industry. The industry median Operating Margin % is 3.24. Conmed's value of 10.60% is 227.2% above this benchmark. Historically, Conmed's own Operating Margin % has ranged from 4.93 to 15.33 over the past decade. While the company's 10-year median is 7.87 vs. the industry median of 3.24, Conmed has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.24, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Conmed's current Operating Margin % of 10.60% is 227.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Conmed and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Conmed's current Operating Margin % is 10.60%, which is 35% above median its own 10-year median of 7.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Conmed (MEX:CNMD) has a current Operating Margin % of 10.60%. The stock's GF Value™ is MXN945.33, compared to a current price of MXN720.00 — trading 23.8% below its estimated fair value. The current Operating Margin % is 10.60%, which is 35% above median its 10-year median of 7.87 and 227.2% above the Medical Devices & Instruments industry median of 3.24. Conmed's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Conmed (MEX:CNMD), the current Operating Margin % is 10.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Conmed (MEX:CNMD) Overvalued in 2026?
Based on GuruFocus' analysis, Conmed stock appears to be undervalued.
The current stock price of MXN720.00 is trading 23.8% below its estimated GF Value™ of MXN945.33.
Key valuation signals for MEX:CNMD:
Operating Margin %: 10.60% (35% above median its 10-year median of 7.87)
GF Value™: MXN945.33 vs. price of MXN720.00 (23.8% below fair value)
Industry Position: 227.2% above the Medical Devices & Instruments median (#324 of 814)
No single metric tells the full story. See the MEX:CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score
Get the complete analysis for MEX:CNMD
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CNMD has been successfully added to your 
